DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to ...

Ultrahuman has expanded its digital health ecosystem with the US launch of M2 Live, an updated metabolic health platform that integrates continuous glucose data from Abbott’s over-the-counter Lingo ...

Insulet (PODD) stock and DexCom (DXCM) receive new Buy ratings from Deutsche Bank while Tandem Diabetes Care (TNDM) stock ...

Dexcom is transforming its Stelo CGM into a whole-family wellness device, securing FDA clearance for pediatric use and debuting new AI tools.

Compare the best Samsung Watch CGM apps and Wear OS tools for blood sugar readings, including Dexcom G6, Gluroo, and xDrip+.

Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience.

OTC glucose monitors are moving into wearable health tech, but the clearest benefits remain for diabetes and prediabetes ...

The wearable patch market is estimated at roughly $ 13- $15 billion in 2026 and is expected to reach the low-twenties of ...

Playful Digits today announced the launch of Level Up Math, an adaptive K-8 math practice platform that helps parents find and fix their child's math gaps before high school exposes them. On the 2024 ...

Looking ahead to 2030, our model projects DXCM could trade at an average price of $125.48, with a potential range between $94.11 and $156.85. This represents a potential 79.9% return from today's ...

Azul, the trusted leader in enterprise Java for today's AI and cloud-first world, today announced that EWE AG, one of Germany's leading energy and infrastructure companies, has cut its Java licensing ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...